Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial - Concepedia

Concepedia

Publication | Closed Access

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

366

Citations

21

References

2021

Year

Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael, Kwee Yong, Marcelo Capra, Thierry Façon, Roman Hájek, Ivan Špıčka, Ross Baker, Gracia Martínez,

Hematological MalignancyRelapsed Multiple MyelomaMedicineRandomised Phase 3ImmunologyHematologyPathologyClinical TrialsImmune Checkpoint InhibitorPharmacotherapyImmunotherapyOncologyRadiation OncologyHealth Sciences

References

	Year	Citations

Page 1

Page 1